XBI icon

SPDR S&P Biotech ETF

699 hedge funds and large institutions have $7.06B invested in SPDR S&P Biotech ETF in 2022 Q1 according to their latest regulatory filings, with 123 funds opening new positions, 242 increasing their positions, 185 reducing their positions, and 112 closing their positions.

Holders
699
Holders Change
+1
Holders Change %
+0.14%
% of All Funds
11.06%
Holding in Top 10
20
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.32%
New
123
Increased
242
Reduced
185
Closed
112
Calls
$2.67B
Puts
$2.59B
Net Calls
+$79M
Net Calls Change
+$799M
Name Market Value Shares Shares
Change
Shares
Change %
RG
801
Retirement Group
California
-100 Closed
CPFP
802
Clear Perspectives Financial Planning
Ohio
-70 Closed
RPCONE
803
Retirement Planning Company of New England
Rhode Island
-59 Closed
SCM
804
Segantii Capital Management
Hong Kong
-50 Closed
RI
805
Rinkey Investments
California
-44 Closed
TCWM
806
Total Clarity Wealth Management
Illinois
-39 Closed
LC
807
Lindbrook Capital
California
-38 Closed
FFG
808
Ford Financial Group
California
-38 Closed
PVH
809
Psagot Value Holdings
Israel
-35 Closed
CCM
810
Chilton Capital Management
Texas
-30 Closed
EIM
811
Elliott Investment Management
Florida
CM
812
Capula Management
Cayman Islands
HM
813
HealthCor Management
New York
AG
814
Artal Group
Luxembourg
CAC
815
Cowen and Company
New York
IM
816
Islet Management
New York
CAM
817
CenterStar Asset Management
Illinois
SFM
818
Sphera Funds Management
Israel
GPCM
819
Granite Point Capital Management
Massachusetts
PHP
820
Parkman Healthcare Partners
Connecticut
DAM
821
DLD Asset Management
New York
EP
822
Eversept Partners
New York
Nomura Holdings
823
Nomura Holdings
Japan
CWP
824
Concord Wealth Partners
Virginia
$0 5
SI
825
Sofinnova Investments
California